# Research Training Program in ImmunoEngineering

> **NIH NIH T32** · GEORGIA INSTITUTE OF TECHNOLOGY · 2021 · $199,695

## Abstract

Abstract 
 
With the burgeoning of the fields of immunology and immunotherapy in the last few decades, the use of
pharmaceutical products, biomedical devices, and biomaterials in immunological research and clinical
applications has rapidly expanded. Accordingly, there has been an increasing need for engineers trained with
the quantitative skills necessary for developing effective immunotherapies and with the skills to translate these
developments to industry. Immunology is a basic science that has a lot of applications that need to be
translated to positively impact patients' lives (e.g. anti-inflammatory or immunosuppressive drugs, avoiding
transplant rejection, adoptive cell therapy for cancer treatment). Most companies working in this area of
ImmunoEngineering hire basic scientists since immunology is a basic science, albeit one that has a lot of
applications amenable to translation in order to positively impact patients' lives (e.g. anti-inflammatory or
immunosuppressive drugs, avoiding transplant rejection, adoptive cell therapy for cancer treatment). However,
these individuals do not have training in engineering nor quantitative or systems perspectives. In contrast,
engineers are also hired into companies that work in ImmunoEngineering areas, but often they do not have
immunology training. The training program described in this application is aimed to better equip engineers by
training them in immunology (as well as in engineering). Through this ImmunoEngineering training program,
we will develop a new type of engineering trainee, one who can apply engineering principles with knowledge of
immunology to make impacts on new treatments for disease and who will fill a critical gap in existing
bioengineers entering today's work force. Our training program will furthermore provide professional
development and ethics training to equip trainees with important “soft skills” such as project and time
management, ethics and personal insight into their character attributes to best position them for leadership
positions in ImmunoEngineering industry and research.

## Key facts

- **NIH application ID:** 10264789
- **Project number:** 5T32EB021962-05
- **Recipient organization:** GEORGIA INSTITUTE OF TECHNOLOGY
- **Principal Investigator:** JULIA E BABENSEE
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $199,695
- **Award type:** 5
- **Project period:** 2017-09-01 → 2023-06-05

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10264789

## Citation

> US National Institutes of Health, RePORTER application 10264789, Research Training Program in ImmunoEngineering (5T32EB021962-05). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10264789. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
